Skip to content

Circulating progenitor and mature endothelial cells in moyamoya disease

Circulating progenitor and mature endothelial cells in moyamoya disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-17011116
Enrollment
Unknown
Registered
2017-04-11
Start date
2014-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

moyamoya disease

Interventions

Two groups:Nil

Sponsors

Department of Neurosurgery, 307 Hospital, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 71 Years

Inclusion criteria

Inclusion criteria: The diagnostic criterion for MMD is that cerebral angiography or magnetic resonance angiography must show at least the following findings: (1) stenosis or occlusion of the terminal portion of the intracranial internal carotid artery or proximal portions of the anterior and/or the middle cerebral artery; (2) abnormal vascular networks in the vicinity of the occlusive or stenotic lesions in the arterial phase

Exclusion criteria

Exclusion criteria: An exclusion criterion was the presence of secondary moyamoya phenomenon caused by atherosclerosis, meningitis, Down syndrome, systemic vasculitis, hyperthyroidism, neurofibromatosis, leptospiral infection, or prior skull-base radiation therapy.

Design outcomes

Primary

MeasureTime frame
endothelial progenitor cells;????;

Countries

China

Contacts

Public ContactDuan Lian

Department of Neurosurgery, 307 Hospital, PLA

duanlian307@sina.com+86 010-66947156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026